Kangyue Technology Co Ltd (300391) - Total Assets
Based on the latest financial reports, Kangyue Technology Co Ltd (300391) holds total assets worth CN¥1.92 Billion CNY (≈ $281.48 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Kangyue Technology Co Ltd (300391) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Kangyue Technology Co Ltd - Total Assets Trend (2009–2024)
This chart illustrates how Kangyue Technology Co Ltd's total assets have evolved over time, based on quarterly financial data. Check 300391 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Kangyue Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Kangyue Technology Co Ltd's total assets of CN¥1.92 Billion consist of 56.6% current assets and 43.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0.4% |
| Accounts Receivable | CN¥1.05 Billion | 52.7% |
| Inventory | CN¥42.45 Million | 2.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥77.51 Million | 3.9% |
| Goodwill | CN¥16.37 Million | 0.8% |
Asset Composition Trend (2009–2024)
This chart illustrates how Kangyue Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Kangyue Technology Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kangyue Technology Co Ltd's current assets represent 56.6% of total assets in 2024, a decrease from 59.9% in 2009.
- Cash Position: Cash and equivalents constituted 0.4% of total assets in 2024, down from 8.1% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2009.
- Asset Diversification: The largest asset category is accounts receivable at 52.7% of total assets.
Kangyue Technology Co Ltd Competitors by Total Assets
Key competitors of Kangyue Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Huadong Medicine Co Ltd
SHE:000963
|
China | CN¥39.93 Billion |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
China | CN¥10.37 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥11.13 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
|
China | CN¥1.41 Billion |
|
Celltrion Pharm Inc
KQ:068760
|
Korea | ₩745.80 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
Kangyue Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.50 | 1.00 | 0.81 |
| Quick Ratio | 0.46 | 0.97 | 0.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.11 Billion | CN¥-7.34 Million | CN¥-508.19 Million |
Kangyue Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Kangyue Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 29.40 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -42.1% |
| Total Assets | CN¥2.00 Billion |
| Market Capitalization | $9.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kangyue Technology Co Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Kangyue Technology Co Ltd's assets decreased by 42.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Kangyue Technology Co Ltd (2009–2024)
The table below shows the annual total assets of Kangyue Technology Co Ltd from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.00 Billion ≈ $292.04 Million |
-42.08% |
| 2023-12-31 | CN¥3.45 Billion ≈ $504.22 Million |
-3.71% |
| 2022-12-31 | CN¥3.58 Billion ≈ $523.66 Million |
-15.09% |
| 2021-12-31 | CN¥4.21 Billion ≈ $616.71 Million |
-10.01% |
| 2020-12-31 | CN¥4.68 Billion ≈ $685.28 Million |
+207.46% |
| 2019-12-31 | CN¥1.52 Billion ≈ $222.88 Million |
-26.92% |
| 2018-12-31 | CN¥2.08 Billion ≈ $304.99 Million |
+5.85% |
| 2017-12-31 | CN¥1.97 Billion ≈ $288.12 Million |
+163.19% |
| 2016-12-31 | CN¥748.11 Million ≈ $109.47 Million |
+7.70% |
| 2015-12-31 | CN¥694.64 Million ≈ $101.65 Million |
+1.88% |
| 2014-12-31 | CN¥681.85 Million ≈ $99.78 Million |
+21.13% |
| 2013-12-31 | CN¥562.92 Million ≈ $82.37 Million |
+38.22% |
| 2012-12-31 | CN¥407.28 Million ≈ $59.60 Million |
+23.52% |
| 2011-12-31 | CN¥329.72 Million ≈ $48.25 Million |
+18.59% |
| 2010-12-31 | CN¥278.04 Million ≈ $40.69 Million |
+21.86% |
| 2009-12-31 | CN¥228.17 Million ≈ $33.39 Million |
-- |
About Kangyue Technology Co Ltd
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminators and stack welding machines; and Chinese herbal medicines and hollow capsules, as well as engages in pharmaceutical distribution business. The company wa… Read more